Others stick with one
January 2026: Novo Nordisk launched Wegovy pill (once-daily oral semaglutide 25 mg) in the United States on January 5, following its December 22, 2025, FDA approval
Designed to be fast-absorbing and comfortable for daily morning and evening use, this eye cream helps maintain hydration while supporting overall eye contour care
"Complementary and Alternative Therapies as Treatment Approaches for Interstitial Cystitis"
In addition, the application of phosphate fertilizers, excess industrial chemical waste, and sewage sludge are actively involved in increasing HMs-toxicity to plants, soils, and environments [3, 4]
Obesity is linked to an increased risk of many cancers, including breast cancer